Category: News

Clinicians from four NHS centres are collaborating to present their use of Omnigen, amniotic membrane in the treatment of ocular conditions. On Tuesday 4th October 2022

NuVision Biotherapies, a tissue-based technology company delivering ophthalmic and wound care solutions in the primary care and surgical setting, join the conference to increase their

Employer profile NuVision (www.nu-vision.co.uk) is a leading UK wound care company, committed to developing and commercialising innovative high quality human tissue products. Our launch focus

Employer profile NuVision (www.nu-vision.co.uk) is a leading UK wound care company, committed to developing and commercialising innovative high quality human tissue products. Our launch focus

NuVision Biotherapies is joining the Department of International Trade (DIT) at Medica World Trade Fair this November to expand their international profile Medica is the

Webinar Round-Up: UK ophthalmologists present on their innovations of amniotic membrane application in the management of ocular surface disease sponsored by NuVision Biotherapies Ltd. The

A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m. Nottingham-based NuVision

UK Company Launches National Registry for Amniotic Membrane Outcomes in Ophthalmology (ROMEO Ophthalmology) This online data registry will allow eye care professionals to record safety

NuVision is looking to recruit an exceptional and committed clinical project associate to provide oversite to our ongoing clinical and new product testing programmes.